Alaunos Market Cap from 2010 to 2026

Stocks . USA . 
Stock . Alaunos Therapeutics
TCRT Stock  USD 3.47  -0.02  -0.57%   
Alaunos Therapeutics' shows a shrinking structural trend supported by multi-year data. Financial forecasts anticipate softening toward approximately 3.3 M. Regression distribution of quarterly values from 2010 to 2026 reveals a arithmetic mean of 355,738,940 . alongside coefficient of variation of 113.89 . View All Fundamentals
 
Market Cap  
 First Reported
2010-12-31
 Previous Quarter
3.5 M
 Current Value
3.3 M
 Quarterly Volatility
405.1 M
Macro event markers
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Financial statement trends for Alaunos Therapeutics provide structured context on operating performance and capital structure. This context pairs drivers like Depreciation And Amortization of 2.2 K, Selling And Marketing Expenses of 4.1 M or Total Revenue of 8.6 K and ratios such as Price To Sales Ratio of 261, Dividend Yield of 0.0294 or PTB Ratio of 1.4 with Alaunos Therapeutics Valuation and Volatility views.
  
Build AI portfolio with Alaunos Stock
Alaunos Therapeutics Correlation provides competitor comparison context for Alaunos Therapeutics. The view supports competitor context.
Our How to Buy Alaunos Stock guide explains the steps to invest in Alaunos Therapeutics stock.
The evolution of Market Cap for Alaunos Therapeutics provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Alaunos Therapeutics compares to historical norms and industry peers.

Latest Alaunos Therapeutics' Market Cap Growth Pattern

Below is the plot of the Market Cap of Alaunos Therapeutics over the last few years. It is Alaunos Therapeutics' Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alaunos Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Market Cap10 Years Trend
Slightly volatile
Compare to OthersAll Fundamentals
   Market Cap   
       Timeline  

Alaunos Market Cap Regression Statistics

Arithmetic Mean 355,738,940
Geometric Mean 113,406,881
Coefficient Of Variation 113.89
Mean Deviation 323,043,970
Median 233,694,964
Standard Deviation 405,149,319
Sample Variance164146T
Range1B
R-Value-0.60
Mean Square Error112835.2T
R-Squared 0.36
Significance 0.01
Slope-47,840,827
Total Sum of Squares2626335.5T

Alaunos Market Cap History

20263.3 M
20253.5 M
20243.1 M
202317 M
2022140.9 M
2016233.7 M

About Alaunos Therapeutics Inc

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. Alaunos Therapeutics, Inc. is headquartered in Houston, Texas. Alaunos Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people. As a micro-cap equity, Alaunos Therapeutics is reviewed for growth durability, margin stability, and risk discipline. Current metrics include P/B of 2.86. Alaunos Therapeutics has market cap of 7.79 M, ROE of -145.65%.

Methodology

Unless otherwise specified, financial data for Alaunos Therapeutics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Alaunos (USA Stocks:TCRT) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The dataset for Alaunos Therapeutics incorporates public filings and market reference sources and official institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Some inputs may not update instantaneously. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Alaunos Therapeutics may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Alaunos Stock Analysis

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY